Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing.
- DOI
- 10.1177/10430342261430765
- Published
- 2026 May
- Container
- Human gene therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/10430342261430765,
title = {Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing.},
author = {Gouda P and Cohen L and Berelowitz K and Bollinger J and Bruno J and Cehelsky J and Charo RA and Harrop J and Kahn J and McGuire AL and O'Rourke P and Patel N and Patin E and Reece TL and Regenberg A and Rocha R and Webster H and Weinfurt K and Sugarman J and Hernandez AF},
year = {2026},
journal = {Human gene therapy},
doi = {10.1177/10430342261430765},
url = {https://doi.org/10.1177/10430342261430765}
}RIS
TY - JOUR TI - Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing. AU - Gouda P AU - Cohen L AU - Berelowitz K AU - Bollinger J AU - Bruno J AU - Cehelsky J AU - Charo RA AU - Harrop J AU - Kahn J AU - McGuire AL AU - O'Rourke P AU - Patel N AU - Patin E AU - Reece TL AU - Regenberg A AU - Rocha R AU - Webster H AU - Weinfurt K AU - Sugarman J AU - Hernandez AF PY - 2026 JO - Human gene therapy DO - 10.1177/10430342261430765 UR - https://doi.org/10.1177/10430342261430765 ER -
APA
P, G., L, C., K, B., J, B., J, B., J, C., RA, C., J, H., J, K., AL, M., P, O., N, P., E, P., TL, R., A, R., R, R., H, W., K, W., J, S., & AF, H. (2026). Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing.. Human gene therapy. https://doi.org/10.1177/10430342261430765
Source records
- pubmed · retrieved 2026-09-26T23:33:44.405Z